Category Archives: Anxiety

CES Ultra is a non-drug approach to treatment of anxiety

Kids on Drugs (Thanks to Parents and Doctors)

Part I: The Dangers

Part II

Parents and Doctors are often overwhelmed when having to deal with ADHD kids. They often look for a shortcut—prescription drugs. Common brand names include stimulants such as Ritalin, Concerta, Adderall, Metadate, Vyvanse, and Provigil. Use of such drugs has reached epidemic proportions. The figures are staggering:

kids-on-drugs

 

More than 1 in 10 (11%) US school-aged children had received an ADHD diagnosis by a health care provider by 2011, as reported by parents.

o    6.4 million children reported by parents to have ever received a health care provider diagnosis of ADHD , including:

  • 1 in 5 high school boys
  • 1 in 11 high school girls

 

The percentage of US children 4-17 years of age with an ADHD diagnosis by a health care provider, as reported by parents, continues to increase.

o    A history of ADHD diagnosis by a health care provider increased by 42% between 2003 and 2011:

  • 7.8% had ever had a diagnosis in 2003
  • 9.5% had ever had a diagnosis in 2007
  • 11.0% had ever had a diagnosis in 2011

o    Average annual increase was approximately 5% per year

The percentage of children 4-17 years of age taking medication for ADHD, as reported by parents, increased by 28% between 2007 and 2011.

o    Percentage of children taking medication for ADHD was:

  • 4.8% in 2007
  • 6.1% in 2011

o    Average annual increase was approximately 7% per year

The average age of ADHD diagnosis was 7 years of age, but children reported by their parents as having more severe ADHD were diagnosed earlier.

o    8 years of age was the average age of diagnosis for children reported as having mild ADHD

o    7 years of age was the average age of diagnosis for children reported as having moderate ADHD

o    5 years of age was the average age of diagnosis for children reported as having severe ADHD

More US children were reported by their parents to be receiving ADHD treatment in 2011 compared to 2007, however treatment gaps may exist.

o    In 2011, as many as 17.5% of children with current ADHD were reported by their parents as not receiving either medication for ADHD or mental health counseling

o    More than one-third of children reported by their parents as not receiving treatment were also reported to have moderate or severe ADHD

The patterns in ADHD diagnosis and medication treatment showed increases in the percentages overall, however some new patterns emerged between 2007 and 2011.

o    The percentage of children reported by their parents to have a history of health care provider diagnosed ADHD increased for most demographic groups (for example, across racial groups, boys and girls) from 2003 to 2011; however,

o    Between 2007 and 2011, the percentage of children reported by their parents to have a history of a health care provider diagnosed ADHD:

  • Was similar among older teens
  • Decreased among multiracial children and children of other races when compared to black or white children

The number of US families impacted by ADHD continues to increase.

o    An estimated 2 million more children were reported by their parents to be diagnosed by a health care professional with ADHD in 2011, compared to 2003

  • By 2011, 6.4 million children were reported by their parents to be diagnosed by a health professional with ADHD compared to 4.4 million in 2003

o    An estimated 1 million more children were reported by their parents to be taking medication for ADHD in 2011, compared to 2003.

  • By 2011, 3.5 million children were reported by their parents to be taking medication for ADHD compared to 2.5 million in 2003

kids-adhd-drugs

These figures should give pause for consideration. By increasing children’s dependence on pharmaceuticals, they learn that the best and easiest way to deal with their emotional issues is by taking a drug, perfect training for their adult years and an added incentive to graduate to recreational drug use and an increased reliance and dependence on prescriptions as a pathway to health.

ADHD Drug Warnings:

There have been 44 warnings from eight countries (United States, United Kingdom, Canada, Japan, Australia, New Zealand, France and Singapore) warning that ADHD drugs/stimulants cause harmful side effects. These include the following (note that some warnings cite more than one side effect, so the list below may not be equal to the total number of warnings):

  • 13 warnings on stimulants causing heart problems
  • 10 warnings on stimulants causing mania/psychosis
  • 9 warnings on stimulants causing cardiovascular problems
  • 8 warnings on stimulants causing death
  • 4 warnings on stimulants causing hallucinations
  • 4 warnings on stimulants causing depression
  • 4 warnings on stimulants causing violence, hostility or aggression
  • 4 warnings on stimulants causing seizures
  • 3 warnings on stimulants causing agitation or irritability
  • 3 warnings on stimulants causing anxiety
  • 2 warnings on stimulants causing suicide risk/attempts
  • 2 warnings on stimulants causing addiction or dependence

ADHD Drug Studies:

There are 25 studies from five countries (United States, Australia, Denmark, Canada and Italy) showing that ADHD drugs/stimulants cause harmful side effects. These include the following (note that some studies cite more than one side effect, so the list below may not be equal to the total number of studies):

  • 5 studies on stimulants causing addiction/medication abuse
  • 5 studies on stimulants causing heart problems
  • 5 studies on stimulants showing lack of efficacy of the drug
  • 4 studies on stimulants causing stunted growth
  • 2 studies on stimulants causing death
  • 1 study on stimulants causing suicide risk/attempts
  • 1 study on stimulants causing violence
  • 1 study on stimulants causing homicidal ideation
  • 1 study on stimulants causing irritability
  • 1 study on stimulants causing depression
  • 1 study on stimulants causing mania, psychosis and hallucinations

Isn't it time we examined a drug-free alternative? The CES Ultra is exactly that—a safe and effective modality with no negative side-effect

Kids on Drugs ( Thanks to Parents and Doctors) – part 2

Part 2: How CES, the Drug Free Alternative, Can Make a Difference

Part 1

One Parent’s Experience

CES Ultra Improves Sleep, Reduces Anxiety, Irritability, and Depression in 14-year-old Male

We’ve been doing a trial with the CES Ultra the past week. The subject was DS*, our 14 year old with diagnosed insomnia, anxiety, and depression. He used the unit for 20 minutes per day, at bedtime.

I would rate the improvement in apparent anxiety and depression to be significant. Anxieties are no longer a major topic of discussion. DS is starting to leave the house on his own for activities other than school. He’s walked outside for exercise many days since starting the program. Last night he performed with his school orchestra and said he didn’t feel strung out about it like he usually has in the past. He settled down well afterwards, which is a first.

Insomnia has shown moderate improvement. We had hoped for more improvement in that department, but perhaps we will see this continue over a longer term. DS does like to use it at bedtime, finds it easier to fall asleep. He is no longer asking for a prescription for sleeping pills. But still some early-morning wakening, etc.

My DH and I find our son more talkative, less defensive, and quite a bit more mellow in the past week. That is something we have not seen for a long time. Irritability has been markedly decreased … now closer to normal teenage irritability than what we endured before. I suspect the reduced anxiety and reduced depression are contributing to the mellower kid.

Side effects: DS feels dozy after using it. Would not do a treatment just before driver’s ed. No negative side effects otherwise noted.

Our family gives CES an “A” grade and a “thumbs up.” The unit’s positive effect on our anxious, depressed, irritable, insomniac teen has taken a lot of stress off of the entire family. And I must add, finding a psych doc who gave us a free (with consult) week-long trial period on the device was very helpful before making the full investment in purchase, which we plan to do.

* (For the sake of privacy, identities are withheld.)

Brief Research Study

Smith, Ray B., McCusker, Charles F., Jones, Ruth G., and Goates, Delbert T.  The use of cranial electrotherapy stimulation in the treatment of stress related attention deficit disorder, with an eighteen month follow up. Unpublished, 1991 and follow-up in 1993.

This study compared the effects of 3 randomly assigned CES devices which had marked differences in electrical stimulation parameters, in the treatment of stress related attention deficit disorder in 23 children and adults, 9 males, 14 females, 9 – 56 years old (average 30.96) with an average education level of 10.56 years. All had been diagnosed as having generalized anxiety disorder (61%), and/or depression (45%), and/or dysthymia (17%). 8 had a primary diagnosis of ADD. CES treatments were given daily, 45 minutes per day for 3 weeks. All 3 CES devices were equally effective based on Duncan’s Range test in significantly (P<.001) reducing depression as measured on the IPAT depression scale (mean of 19.38 ± 8.44 pretest to 13.19 ± 7.00 post test), state and trait anxiety scales of the STAI (mean state anxiety was reduced from 39.95 ± 11.78 pretest to 29.76 ± 6.99 post test, and the mean trait anxiety was reduced from 43.90 ± 11.31 pretest to 32.19 ± 7.50 post test), and in increasing the Verbal pretest (mean of 99.38 ± 13.20 to post test of 107.50 ± 14.13), Performance (mean of 107.4 ± 15.05 to 126.6 ± 14.2 ), and Full Scale I.Q. scores on the WISC-R or WAIS-R IQ tests (mean of 103.2 ± 13.7 to 117.6 ± 14.28). The authors concluded that in the unlikely event that our findings are the results of placebo effect alone, a CES device, retailing at approximately $795, would still be a relatively inexpensive and apparently reliable treatment for such a debilitating disorder as stress related ADD. On 18 month follow up, the pts performed as well or better than in the original study, the Full Scale IQ had not moved significantly from where it was after the first 3 weeks of treatment, the Performance IQ fell back slightly, while the Verbal IQ continued to increase. There did not seem to be any pattern of addiction to or over dependence on the CES device. There was no side effects except for 1 pt who cried during treatments, and 1 who was sore behind the ears when the electrode gel began drying out.

The cornerstone tenet of medicine is “Do no harm.” Don’t you owe it to your child to try a safe, effective, non-invasive approach before turning to drugs? Consider the CES Ultra.

Another Therapist Reports: CES Intervention Diffuses Anger, Decreases Hyper-Irritability, & Improves Health of 21-year-old Female College Student after Other Therapies Fail.

Why Psychiatry needs CES (Cranial Electrotherapy Stimulation)

INSOMNIA

Many patients benefit from improving sleep hygiene and as a treatment for insomnia.

Others may improve using a sleep phase changes or treating the underlying problem such as sleep apnea, medical conditions, alcohol abuse, etc.

For many others, recent pharmacologic treatments prove effective and have minimal side effects. Targeting melatonin receptors is a novel and promising approach.

For many persons, however, existing treatments are ineffective, too expensive, result in side effects or conflict with their desire to avoid medications. Some side effects from medications are very disturbing, such as sleep associated behaviors that result in harm to self or others. For others, there is morning sedation, drug/drug interactions or rebound insomnia. When behavioral interventions are not effective, CES could be considered prior to initiating medications.

ANXIETY

There are many non-pharmacologic interventions for reducing anxiety. Some of these include dietary supplements, acupuncture, meditation, yoga, and exercise. These interventions, however, are not employed by a large segment of society that suffers from anxiety. These persons instead seek medications from their physician to alleviate their suffering. Typical classes of medications for anxiety include the SSRI’s, benzodiazepines as well as the off label use of antihistamines and atypical antipsychotic medications and antiepileptic medications. In addition to the inherent problems with SSRI’s, there are also problems with the other classes of medications. A serious potential side effect of benzodiazepines is their potential for inducing physical and psychological dependence. In addition, withdrawal symptoms can prove life threatening, especially with the shorter acting benzodiazepines like alprazolam. When taken as directed, which is often not the case; this class of medications can result in compromised coordination, slowed reaction time, falls, disinhibition, delirium, and anterograde amnesia.

It is not uncommon to see suicide attempts involving a combination of a benzodiazepines together with alcohol and/or another sedative hypnotic. While buspirone is relatively well tolerated, it has poor efficacy and a 3 to 4 week lag time to have an effect. Medications such as gabapentin are used off label but there is no research to support its efficacy for anxiety disorders. Unfortunately, physicians have begun using the atypical antipsychotic medications to treat anxiety. This class of medications has a large and increasing number of very serious side effects. Recent attention has been focused on their causing metabolic syndrome. They frequently cause extra pyramidal side effects, sedation, elevated prolactin levels and drug/drug interactions. All of these medications should be avoided during pregnancy and used with caution in the elderly. In short, the side effect profile of current pharmacologic treatments for anxiety limits their safe use.

DEPRESSION

There is considerable controversy regarding the efficacy for evidence based treatments for depression. The controversy also involves the risk/benefit analyses of currently approved interventions. While the primary focus has been on medications, similar concerns have been raised regarding certain psychotherapies, transcranial electromagnetic stimulation, vagal nerve stimulation, ECT and herbal and dietary supplements.

Through articles published in the lay press, the general public has been apprised of the controversy involving the efficacy of antidepressant medications. For example, Time magazine recently cited Kirsch’s meta-analysis in PLoS Medicine that found little benefit of antidepressants for most patients as well as Dr. John Krystal’s findings that about 25% of patients did worse on antidepressants than on placebo”. They have been informed about the black box warnings for SSRI’s causing suicidal behaviors. One of the results of this publicity is a growing movement away from all medications to “holistic” or “folk remedies”. In fact, there many patients express fears of taking medications.

There is excellent data and clinical experience however to support the safety and lack of adverse side effects from CES and it should be included in the spectrum of available treatments as it poses very low risk of harm to patients.

Excerpts from “A View from the Trenches” written by Jason Worchel, M.D.

More CES Research – http://www.cesultra.com/research-resources.htm

Fears of dentists cured by Cranial Electrotherapy

Experts believe electrotherapy is the key to solving anxiety related to the dentist. MILLIONS of people could be cured of their fear of dentist surgeries with the help of electrotherapy, new research has claimed

Tiny electrical currents into the brain could help solve people’s terrifying phobia of the dentist.

Experts said a handheld device which transmits cranial electrotherapy stimulation (CES) reduced anxiety among those with a long fear of dentists.

The study conducted in Nigeria for the Journal of Dental and Medical Sciences said the treatment is similar to the TENS machines used by pregnant women.

The device stimulates nerves for therapeutic purposes and is used by expectant mothers for pain relief.

The research scientists carried out tests on 40 adults scared of the dentist and divided them into four groups.

cranial-electrotherapy-for-dentist

One group were treated with CES, another had relaxation therapy, a third group had both treatments while a fourth had none.

Relaxation therapy involved patients spending 30 minutes with a specialist trainer who taught them exercises to help lower anxiety levels.

The CES worked just as well as the relaxation therapy after 45 minutes.

Whereas having both treatments had no extra benefits but all were far more effective then doing nothing to curb anxiety related to the dentist.

Read more – http://www.express.co.uk/life-style/health

A View from the Trenches: Why Psychiatry needs CES – Part 2

Anxiety

There are many non-pharmacologic interventions for reducing anxiety. Some of these include dietary supplements, acupuncture, meditation, yoga, and exercise. These interventions, however, are not employed by a large segment of society which suffers from anxiety. These persons instead seek medications from their physician to alleviate their suffering.

ces-treat-anxiety

Typical classes of medications for anxiety include the SSRI’s, benzodiazepines as well as the off label use of antihistamines and atypical antipsychotic medications and antiepileptic medications. In addition to the inherent problems with SSRI’s, there are also problems with the other classes of medications.

A serious potential side effect of benzodiazepines is their potential for inducing physical and psychological dependence. In addition, withdrawal symptoms can prove life threatening, especially with the shorter acting benzodiazepines like alprazolam. When taken as directed, which is often not the case; this class of medications can result in compromised coordination, slowed reaction time, falls, disinhibition, delirium, and anterograde amnesia.

It is not uncommon to see suicide attempts involving a combination of a benzodiazepines together with alcohol and/or another sedative hypnotic. While buspirone is relatively well tolerated, it has poor efficacy and a 3 to 4 week lag time to have an effect. Medications such as gabapentin are used off label but there is no research to support its efficacy for anxiety disorders.

Unfortunately, physicians have begun using the atypical antipsychotic medications to treat anxiety. This class of medications has a large and increasing number of very serious side effects. Recent attention has been focused on their causing metabolic syndrome. They frequently cause extra pyramidal side effects, sedation, elevated prolactin levels and drug/drug interactions. All of these medications should be avoided during pregnancy and used with caution in the elderly.

In short, the side effect profile of current pharmacologic treatments for anxiety limits their safe use. CES is a safe, initial alternative to such medications.

By Jason Worchel, M.D., a noted psychiatrist and Director of the Hilo Mental Health Center in Hilo, HI. This post is from a paper written by Dr. Worchel in his testimony before the F.D.A. concerning the effectiveness and safety of CES from the perspective of a practicing psychiatrist.